The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario

Joana Nicolau, Antelm Pujol Calafat, Apolonia Gil, Jorge Blanco Anesto

Open source

DOI
10.20960/nh.05244
Published
2024
Container
Nutrición Hospitalaria
Publisher
ARAN Ediciones
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.20960/nh.05244,
  title = {The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario},
  author = {Joana Nicolau and Antelm Pujol Calafat and Apolonia Gil and Jorge Blanco Anesto},
  year = {2024},
  journal = {Nutrición Hospitalaria},
  doi = {10.20960/nh.05244},
  url = {https://doi.org/10.20960/nh.05244}
}

RIS

TY  - JOUR
TI  - The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario
AU  - Joana Nicolau
AU  - Antelm Pujol Calafat
AU  - Apolonia Gil
AU  - Jorge Blanco Anesto
PY  - 2024
JO  - Nutrición Hospitalaria
DO  - 10.20960/nh.05244
UR  - https://doi.org/10.20960/nh.05244
ER  - 

APA

Nicolau, J., Calafat, A. P., Gil, A., & Anesto, J. B. (2024). The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario. Nutrición Hospitalaria. https://doi.org/10.20960/nh.05244

Source records